Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-08-10 Purchase | 2021-08-10 8:06 pm | Dicerna Pharmaceuticals Inc | DRNA | FAMBROUGH DOUGLAS President and CEO | 5,000 | $22.1 | $110,480 | 43,164 (Direct) | View |
| 2020-09-01 Purchase | 2020-09-01 8:33 pm | Dicerna Pharmaceuticals Inc | DRNA | FAMBROUGH DOUGLAS President and CEO | 10,000 | $18.06 | $180,597 | 22,300 (Direct) | View |
| 2019-12-17 Sale | 2019-12-19 8:54 pm | Dicerna Pharmaceuticals Inc | DRNA | FAMBROUGH DOUGLAS Chief Executive Officer | 139,021 | $26 | $3,613,931 | 213,550 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-06-22 Option Award | 2022-06-24 06:33 am | N/A 2032-06-22 | Oncorus Inc. | ONCR | FAMBROUGH DOUGLAS Director | 25,000 | $0 | 25,000 (Direct) | View |
Ownership | 2022-06-24 06:30 am | N/A 2032-01-03 | Oncorus Inc. | ONCR | FAMBROUGH DOUGLAS Director | 0 | $0 | 15,000 (Direct) | View |
| 2021-12-28 Disposition | 2021-12-29 4:19 pm | N/A N/A | Dicerna Pharmaceuticals Inc | DRNA | FAMBROUGH DOUGLAS Chief Executive Officer | 2,808,335 | $0 | 0 (Direct) | View |
| 2021-12-28 Disposition | 2021-12-29 4:19 pm | N/A N/A | Dicerna Pharmaceuticals Inc | DRNA | FAMBROUGH DOUGLAS Chief Executive Officer | 231,431 | $38.25 | 0 (Direct) | View |
| 2021-12-15 Tax Withholding | 2021-12-17 4:16 pm | N/A N/A | Dicerna Pharmaceuticals Inc | DRNA | FAMBROUGH DOUGLAS Chief Executive Officer | 5,348 | $38.05 | 272,681 (Direct) | View |
| 2021-12-15 Exercise | 2021-12-17 4:16 pm | N/A N/A | Dicerna Pharmaceuticals Inc | DRNA | FAMBROUGH DOUGLAS Chief Executive Officer | 13,750 | $0 | 272,681 (Direct) | View |
| 2021-12-10 Exercise | 2021-12-13 7:33 pm | N/A 2027-01-03 | Dicerna Pharmaceuticals Inc | DRNA | FAMBROUGH DOUGLAS Chief Executive Officer | 179,865 | $0 | 469,414 (Direct) | View |
| 2021-12-10 Exercise | 2021-12-13 7:33 pm | N/A N/A | Dicerna Pharmaceuticals Inc | DRNA | FAMBROUGH DOUGLAS Chief Executive Officer | 33,670 | $2.97 | 469,414 (Direct) | View |
| 2021-12-10 Exercise | 2021-12-13 7:33 pm | N/A N/A | Dicerna Pharmaceuticals Inc | DRNA | FAMBROUGH DOUGLAS Chief Executive Officer | 146,195 | $3.42 | 469,414 (Direct) | View |
| 2021-01-08 Tax Withholding | 2021-01-12 9:38 pm | N/A N/A | Dicerna Pharmaceuticals Inc | DRNA | FAMBROUGH DOUGLAS President and CEO | 6,159 | $23.29 | 399,580 (Direct) | View |
| 2021-01-12 Option Award | 2021-01-12 9:38 pm | N/A N/A | Dicerna Pharmaceuticals Inc | DRNA | FAMBROUGH DOUGLAS President and CEO | 302,700 | $0 | 399,580 (Direct) | View |
| 2021-01-08 Exercise | 2021-01-12 9:38 pm | N/A N/A | Dicerna Pharmaceuticals Inc | DRNA | FAMBROUGH DOUGLAS President and CEO | 19,950 | $0 | 399,580 (Direct) | View |
| 2020-01-08 Option Award | 2020-01-10 8:04 pm | N/A N/A | Dicerna Pharmaceuticals Inc | DRNA | FAMBROUGH DOUGLAS Chief Executive Officer | 329,800 | $0 | 329,800 (Direct) | View |
| 2019-12-18 Exercise | 2019-12-19 8:54 pm | N/A 2023-09-24 | Dicerna Pharmaceuticals Inc | DRNA | FAMBROUGH DOUGLAS Chief Executive Officer | 80,000 | $0 | 213,550 (Direct) | View |
| 2019-12-18 Exercise | 2019-12-19 8:54 pm | N/A N/A | Dicerna Pharmaceuticals Inc | DRNA | FAMBROUGH DOUGLAS Chief Executive Officer | 80,000 | $3.42 | 213,550 (Direct) | View |